2-Decarboxy-2-tetrazolyl-13,14-dihydro-PG.sub.2 compounds

Abstract

The present invention provides novel 2-decarboxy-2-tetrazolyl-13,14-dihydro-PG.sub.2 compounds methods for their preparation and pharmacological use for the induction of prostaglandin-like effect.

Description

BACKGROUND OF THE INVENTION

The present invention relates to novel prostaglandin analogs. Particularly, these compounds are analogs of the prostaglandins wherein the C-20-C-19 position is unsaturated, i.e., 19,20-didehydro-PG compounds. Most particularly, the present invention relates to novel 2-decarboxy-2-tetrazolyl-13,14-dihydro-PG.sub.2 compounds, a disclosure of the preparation and use of which is incorporated here by reference from U.S. Ser. No. 025,899, filed Apr. 2, 1979, now 4,228,104, issued Oct. 14, 1980.

PRIOR ART

Prostaglandin analogs exhibiting unsaturation in the C-17, C-18, or C-20 position are known in the art. See, for example, U.S. Pat. No. 3,919,285 German Offenlegungsschrift 2,635,985 (and its corresponding Derwent Farmdoc CPI No. 10302A), and U.S. Pat. No. 4,064,351 for examples of such compounds. See also the reference cited in U.S. Ser. No. 026,066.

SUMMARY OF THE INVENTION

The present invention particularly provides: A compound of the formula ##STR1## where D is (1) cis--CH.dbd.CH--CH.sub.2 --(CH.sub.2).sub.g --CH.sub.2 --,

(2) cis--CH.dbd.CH--CH.sub.2 --(CH.sub.2).sub.g --CF.sub.2 --, (3) cis--CH.sub.2 --CH.dbd.CH--CH.sub.2 --C.sub.2 --, (4) trans-(CH.sub.2).sub.3 --CH.dbd.CH--, wherein Q is ##STR2## wherein R.sub.5 is hydrogen or methyl, wherein R.sub.2 is hydrogen, hydroxyl, or hydroxymethyl; wherein R.sub.3 and R.sub.4 are hydrogen, methyl, or fluoro, being the same or different, with the proviso that one of R.sub.3 and R.sub.4 is fluoro only when the other is hydrogen or fluoro; wherein W is ##STR3## and wherein X is --CH.sub.2 CH.sub.2 --.

The compounds of the present invention are particularly useful for inducing prostaglandin-like biological effects, as is described in U.S. Ser. No. 026,066. Uses of compounds in accordance with the present invention include, therefore, anti-asthmatic indication.

Claims

1. A compound of the formula ##STR4## wherein D is (1) cis--CH.dbd.CH--CH.sub.2 --(CH.sub.2).sub.g --CH.sub.2 --,

(2) cis--CH.dbd.CH--CH.sub.2 --(CH.sub.2).sub.g --CF.sub.2 --,

(3) cis--CH.sub.2 --CH.dbd.CH--CH.sub.2 --CH.sub.2 --,

(4) trans--(CH.sub.2).sub.3 --CH.dbd.CH--,

wherein g is zero, one, 2, or 3,

wherein Q is ##STR5## wherein R.sub.5 is hydrogen or methyl, wherein R.sub.2 is hydrogen, hydroxyl, or hydroxymethyl;

wherein R.sub.3 and R.sub.4 are hydrogen, methyl, or fluoro, being the same or different, with the proviso that one of R.sub.3 and R.sub.4 is fluoro only when the other is hydrogen or fluoro;

wherein W is ##STR6## and wherein X is --CH.sub.2 CH.sub.2 --.